Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Irreversible bone marrow failure with chlorambucil.

P Rudd, J F Fries, W V Epstein

    The Journal of Rheumatology
    |December 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Problems in consultation medicine : The generalist's reply.

    Journal of general internal medicine·2016
    Same author

    Deficiencies in education and experience in the management of acute kidney injury among Malawian healthcare workers.

    Malawi medical journal : the journal of Medical Association of Malawi·2015
    Same author

    Disability outcomes and dose escalation with etanercept, adalimumab, and infliximab in rheumatoid arthritis patients: a US-based retrospective comparative effectiveness study.

    Current medical research and opinion·2012
    Same author

    Lymphoma and luekemia in rheumatoid arthritis: are they associated with azathioprine, cyclophosphamide, or methotrexate?

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
    Same author

    More on scleroderma renal crisis.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008
    Same author

    The epidemiology of NSAID gastropathy: the ARAMIS experience.

    Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases·2008

    Chlorambucil can cause irreversible bone marrow failure, even at lower doses, contrary to previous beliefs. This highlights the need for careful monitoring and avoiding continued use after initial leukopenia during chemotherapy.

    Area of Science:

    • Oncology
    • Hematology
    • Rheumatology

    Background:

    • Chlorambucil is an alkylating agent used to treat various autoimmune diseases and cancers.
    • Leukopenia is a known side effect of chlorambucil, generally considered reversible and dose-dependent.

    Observation:

    • Two cases of irreversible bone marrow failure occurred in patients treated with chlorambucil for rheumatoid disease and systemic lupus erythematosus.
    • The total dosages administered were 398 mg and 1,764 mg, respectively.

    Findings:

    • The observed irreversible bone marrow depression contrasts with the established understanding of chlorambucil's effects.
    • These cases suggest that chlorambucil-induced leukopenia may not always be reversible or strictly dose-related.
    • Idiosyncratic reactions or other factors may contribute to severe, persistent bone marrow toxicity.

    Related Experiment Videos

    Implications:

    • Chlorambucil therapy should be discontinued upon the first sign of leukopenia until peripheral counts and marrow cellularity normalize.
    • Titrating chlorambucil dosage based on leukocyte count, a common practice with other alkylating agents, may be hazardous.
    • Further research is required to elucidate the mechanisms behind irreversible chlorambucil-induced bone marrow failure.